Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Hypertension. 2012 Jul 2;60(3):659–668. doi: 10.1161/HYPERTENSIONAHA.112.193318

Figure 5.

Figure 5

Quantitative assessment of antioxidant efficacy in healthy controls, HFrEF patients, and 3 groups of HTx recipients. (A) plasma ascorbate; (B) Thiobartituric Acid Reactive Substances (TBARS). Values are means ± SE. (*) Significantly different from Controls; (†) Significantly different from Placebo.